Andy discusses the importance of intrinsic value in investment decisions, emphasizing a cautious approach to the market amid rising inflation and interest rates. He highlights a barbell strategy that balances large-cap pharmaceutical stocks with a long-standing commitment to small and mid-cap biotech companies, which drive innovation in the healthcare sector. The conversation also touches on portfolio concentration and risk management, underscoring the significance of diversification across various healthcare subsectors.
